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Au-Mesoporous Silica Nanoparticles Gated with Disulfide-Linked 
Oligo(Ethylene Glycol) Chains for Tunable Cargo Delivery 
Mediated by an Integrated Enzymatic Control Unit  
Antoni Llopis-Lorente,a,b,c Beatriz de Luis,a,b,c Alba García-Fernández,a,b,c Paula Díez,d Alfredo 
Sánchez,d M. Dolores Marcos,a,b,c Reynaldo Villalonga,*d Ramón Martínez-Máñez*a,b,c and Félix 
Sancenóna,b,c
We report a delivery system based on Au-mesoporous silica (MS) 
nanoparticles functionalized with acetylcholinesterase on the Au 
face as a control unit and with disulfide-containing oligo(ethylene 
glycol) chains on the MS face as caps. The control unit handles the 
chemical information in the environment (the presence of 
acetylthiocholine or enzyme inhibitors) that results in a tuned 
cargo delivery from the nanocarrier. The nanodevice displayed an 
enhanced cargo delivery in cancer cells (safranin O and 
doxorubicin) in the presnece of acetylthiocholine.  
 In recent years, the development of smart delivery systems 
able to release their cargo upon application of specific stimuli 
has attracted much attention due to their potential application 
in the biomedical and sensing fields.1 Systems based on 
liposomes, inorganic scaffolds and polymeric nanoparticles 
having different size, structure, surface and delivery properties 
have been reported.2 In addition, researchers are currently 
developing active nanomotors using enzymes as future 
nanovehicles, and some examples are already available.3 
Among potential drug nanocarriers, mesoporous silica (MS) 
supports are especially appealing because of their unique 
properties, such as chemical stability, high loading capacity, 
low cost and biocompatibility.4 Gated MS supports for cargo 
delivery usually contain two subunits: (i) a porous scaffold in 
which a cargo is loaded and (ii) molecular, supramolecular or 
bio-molecular ensembles, placed on the external surface of the 
loaded solid, capable of being “opened” or “closed” on-
command in order to control payload delivery from pores. In 
line with this concept, examples of gated MS supports 
responsive to physical (light, temperature, magnetic fields, 
ultrasounds), chemical (anions, cations, neutral molecules, 
redox-active species and pH) and biochemical (such as 
enzymes, DNA and antibodies) stimuli have been reported.5 
 Inside this area of gated materials, we have recently 
reported the design of more sophisticated nanodevices for 
delivery applications based on Janus nanoparticles with Au and 
MS on opposite faces.6 This allows the immobilization of 
enzymes on the Au face (control unit) and 
molecular/supramolecular gates on the MS face. The role of 
the “control unit” is to handle chemical information (input) of 
the environment and transform it into new molecules that 
control the state of the gate (open or closed) (see Scheme 1). 
Such systems have been used in complex communication 
networks.5h,6c Moreover, this expands the possibilities for the 
construction of smart delivery systems since enzymes can be 
chosen to recognize a large number of different specific 
substrates and produce a certain stimulus, through an enzyme-
mediated process, able to open the gated ensemble. As far as 
we know, very few examples of gated Janus Au-MS 
nanoparticles have been reported and both are based on 




Scheme 1. Representation of a Janus Au-MS nanodevice containing a control unit 
that regulates delivery in the gated MS face. 
  
 With the aim of opening new directions towards the 
construction of smart delivery systems, we report herein the 
first example of an enzyme-controlled Janus Au-MS 
nanodevice in which delivery is driven by a thiol-exchange 
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redox mechanism. Additionally, we also show that cargo 
release can be modulated by the presence of certain 
substances. Usually gated nanodevices exhibited a simple 
delivery upon application of a triggering stimulus. However, in 
our designed system, the control unit is able to detect the 
presence of certain chemicals in the solution (enzyme 
inhibitors) and tune cargo delivery accordingly.  
 Scheme 2 illustrates the design and operation of the 
system. The enzyme acetylcholinesterase was immobilized on 
the Au face of the Janus Au-MS nanoparticles. The MS face 
was loaded with a suitable cargo (safranin O) and its external 
surface was functionalized with disulfide-containing 
oligo(ethylene glycol) chains (SS-OEG) which act as molecular 
gates. The Au side (control unit) was functionalized with 
acetylcholinesterase that is able to detect the presence of 
acetylthiocholine, a derivative of the neurotransmitter 
acetylcholine.7 In particular, the hydrolysis of 
acetylthiocholine8 by the enzyme produces thiocholine that 
cleavages the disulfide bond on the MS face resulting in pore 
opening and payload release. Moreover, the nanodevice is also 
sensitive to the presence of diisopropyl fluorophosphate (DFP) 
which regulates enzyme activity and consequently also cargo 




Scheme 2. Representation of the performance of the nanodevice S3. The 
“control unit” (Au face is functionalized with acetylcholinesterase, which directs 
the cargo delivery form the mesoporous face in the presence of 
acetylthiocholine (ATCh).  
  
 In order to prepare the nanodevice, first MS nanoparticles 
were obtained by hydrolysis and condensation of tetraethyl 
orthosilicate in basic media using cetyltrimethylammonium 
bromide as a template. The surfactant was then removed by 
calcination in air at high temperature which yield the starting 
mesoporous support. In a second step, gold nanoparticles 
were synthesised by reduction of Au(III) with sodium citrate 
based on the Turkevich-Frens method.9 Next, MS 
nanoparticles were confined at the interface of a Pickering 
emulsion between paraffin and an aqueous face in order to 
achieve its partial functionalization with (3-
mercaptopropyl)trimethoxysilane on which Au nanoparticles 
were attached by the formation of S-Au bonds. The paraffin 
wax was removed by washing with CHCl3 which yield the initial 
Janus Au-MS nanoparticles (S1). In a further step, the pores of 
the MS face were loaded with safranin O by stirring overnight 
at room temperature a suspension of the nanoparticles in an 
aqueous solution of the dye. Next, the Au surface was 
functionalized with 3-mercaptopropionic acid, which was 
attached by the formation of Au-S bonds. Afterward, an excess 
of (3-mercaptopropyl)trimethoxysilane was added to 
functionalize the mesoporous surface and the thiol-
functionalized solid was further reacted with 2,2-dipyridyl 
disulfide. Then, substitution of dipyridyl groups by reaction 
with O-(2-mercaptoethyl)-O-methyl-hexa(ethylene glycol) (SS-
OEG) allowed the capping of the mesoporous scaffold yielding 
the nanoparticles S2. Finally, the enzyme acetylcholinesterase 
was immobilized by coupling lysine residues in the enzyme 
with the carboxylic groups on the gold surface via the use of N-
hydroxysuccinimide (NHS) and ethyl(dimethylaminopropyl) 
carbodiimide (EDC).10 This process finally yielded S3 
nanoparticles (see Scheme 3) which were kept wet in the 
refrigerator until use. Nanoparticles similar to S3, but loaded 
with the cytotoxic agent doxorubicin, were also prepared 
(S3DOX, see Supporting Info for details). 
 
 
Scheme 3.  Representation of the Janus Au-MS nanoparticles (S1), capped 
nanoparticles (S2) and enzyme-functionalized nanodevice (S3). 
 
 Solids were characterized using standard procedures (see 
Supporting Information). The mesoporous morphology of the 
MS nanoparticles (diameter of ca. 70-100 nm) as well as the 
presence of the Au nanoparticles (diameter of ca. 20-25 nm) in 
Au-MS colloids was confirmed by transmission electron 
microscopy (TEM) analysis (see Figure 1 and Figure SI-1 for 
additional images). The powder X-ray diffraction (PXRD) 
pattern of the starting MS nanoparticles showed the 
mesoporous characteristic reflection peak (100) around 2.4° 
(see Figure 1). The preservation of this typical peak in S1 and 
S2 clearly confirms that the surface functionalization and cargo 
loading processes did not damage the mesoporous scaffolding. 
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Moreover, the diffraction pattern at high angles for Janus 
colloids showed the cubic gold nanocrystals characteristic 
(111), (200), (220), and (311) peaks,11 confirming the Au-MS 
architecture observed by TEM (see also Figure 1). N2 
adsorption-desorption isotherms of starting MS and S1 
showed an adsorption step at intermediate P/P0 values (0.1-
0.3) which indicates the presence of empty pores (see Figure 
SI-2). BET specific surface area,12 BJH pore volumes13 and pore 
sizes were calculated and are summarized in Table SI-1. 
Moreover, contents of safranin O and SS-OEG groups in S2 
were determined by elemental analysis (see Table SI-2), giving 
values of 52.6 and 137 mg per gram of solid, respectively. 
Furthermore, the activity of immobilized enzyme on the final 
nanodevice S3 was determined to be 797 U·g-1, that 
corresponds to 3.5 mg·g-1 (see Figure SI-3). Moreover, TEM-
EDX mapping of the gold side of the nanodevice shows that 
this area was rich in sulphur atoms (see Supporting 
Information), thus confirming the preferential localization of 




Figure 1. Top: TEM images of (I) calcined mesoporous silica, (II) Janus Au-MS 
nanoparticles (S1) and (III) capped nanoparticles (S2). Down: PXRD of (a) as-
made mesoporous silica, (b) calcined mesoporous silica, (c) Janus Au-MS 
nanoparticles (S1) and (d) capped nanoparticles (S2) at low (left) and high (right) 
angles. 
 
 In order to test the ability of the nanodevice to recognize 
acetylthiocholine, we brought S3 to a concentration of 0.9 
mg·mL-1 in aqueous solution at pH 7.5 (50 mM sodium 
phosphate buffer) in the absence and presence of 
acetylthiocholine (1 mM). Aliquots were taken at scheduled 
times, centrifuged to remove nanoparticles, and cargo release 
was evaluated by measuring the emission band of safranin O 
at 585 nm (λexc = 520 nm). Figure 2 shows payload delivery 
kinetics. In the absence of acetylchiocholine, dye release from 
S3 was negligible. However, presence of acetylthiocholine 
induced pore opening and a subsequent remarkable cargo 
delivery in less than one hour. In addition, we also carried out 
experiments in 50 mM sodium phosphate buffer at different 
relevant pHs, in simulated blood plasma and in PBS (see 
Supporting Information for details) and in all these cases a 
similar behaviour was observed (see Figure 3). The observed 
payload release is attributed to the “detection” of 
acetylthiocholine by acetylcholinesterase in the control unit. 
The enzyme transforms acetylthiocholine into thiocholine, 
which induced cleavage of disulfide bonds in SS-OEG on the 
MS face, finally resulting in uncapping of the pores and cargo 
delivery. Thiocholine is able to break disulphide bonds via a 
thiol-disulfide interchange reaction.14 This reaction consists on 
a nucleophilic substitution of a thiol in disulfides with another 
thiol from a different molecule and plays an important role in 
biochemistry.  
 
Figure 2. Normalized cargo release from S3 determined by measuring safranin O 
fluorescence at 585 nm (λexc = 520 nm) versus time in aqueous solution (50 mM 
sodium phosphate buffer, pH 7.5) in the absence (black) and presence (red) of 
acetylthiocholine 1 mM. Error bars from three independent experiments. 
 
Figure 3. Normalized cargo release from S3 determined by measuring safranin O 
fluorescence at 585 nm (λexc = 520 nm) under different conditions after 120 min. 
From left to right: in the presence of ATCh 1 mM in 50 mM sodium phosphate 
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buffer at pH 7.5 (A), pH 8.5 (B) and pH 6.5 (C); in the presence of ATCh 1 mM in 
simulated body plasma (D) and PBS (E) and in the absence of ATCh in PBS (F). 
 In order to validate the proposed gating mechanism, we 
carried out additional control experiments. First, the response 
of S3 in the presence of acetylcholine was studied. 
Acetylcholine is also hydrolyzed by the enzyme resulting in the 
formation of choline and acetic acid.8 In this case, the release 
from S3 in the presence of acetylcholine was negligible since 
the enzymatic process does not yield thiocholine and therefore 
the MS face remained capped (Figure 4). Release experiments 
in the presence of sodium iodide showed that the anion iodide 
(we used acetylthiocholine iodide for the release experiments 
in Figure 2) had no effect in the response of S3 (Figure 4). 
Moreover, the response of the capped solid S2 (without 
enzyme) in the presence of acetylthiocholine resulted in no 
delivery demonstrating the key role played by the enzyme in 
the “control unit”.  The fact that S3 is able to deliver the cargo 
in the presence of acetylthiocholine and not with acetylcholine 
points out how enzymes and molecular gates can be 
assembled on Janus nanoparticles to operate synergistically 
and recognize small differences on molecular structure. 
 
Figure 4. Normalized cargo release from S3 in aqueous solution (50 mM sodium 
phosphate buffer, pH 7.5) in the presence of acetylthiocholine (ATCh), 
acetylcholine (ACh), and sodium iodide and from S2 (without enzyme) in the 
presence of ATCh after 120 min. 
 
 Encouraged by these findings, we tested in a further step if 
delivery from S3 could also be tuned by the presence of 
enzyme inhibitors. Diisopropyl fluorophosphate (DFP) is a 
known acetylcholinesterase inhibitor which is used in 
neuromedicine, also as a pesticide and as a nerve agent 
simulant.15 In the presence of DFP, acetylcholinesterase is 
phosphorylated at the active site, and accordingly, it was 
expected that acetylthiocholine could not be hydrolyzed.16 In a 
typical experiment, S3 suspensions were incubated with a 
certain concentration of DFP and acetylthiocholine (1 mM). As 
shown in Figure 5, cargo delivery from the MS support can be 
finely tuned depending on DFP concentration. This result 
stresses again the role of the enzyme-based “control unit”, 
which is able to “recognize” the presence of the inhibitor and 
consequently modulate the cargo delivered. Cargo delivery 
from S3 can be modulated using concentrations of DFP as low 
as 5 µM. We also observed a similar response (payload release 
inhibition) with diethyl cyanophosphonate (DCNP), another 
acetylcholinesterase inhibitor (see Figure SI-5) and in a less 
extent with diethyl chlorophosphate (DCP) which indicated 
that cargo delivery can not only be regulated based on the 
amount of inhibitor but also on the inhibitor structure.  
 
  
Figure 5. Normalized cargo release from S3 determined by measuring safranin O 
fluorescence at 585 nm (λexc = 520 nm) versus time in aqueous solution (50 mM 
sodium phosphate buffer, pH 7.5) in the absence (black) and in the presence of 
acetylthiocholine 1 mM previously incubated with DFP 0.5 mM (blue), 0.05 
(green), 0.005 mM (magenta) and without DFP (red). 
Finally, we evaluated the performance of the nanodevice 
at cellular level. For this purpose, the human cervix 
adenocarcinoma (HeLa) cell line was used. First, in order to 
assess the biocompatibility of S3 and discard any toxicity 
associated with the Janus scaffold or the coating shell, cell 
viability assays were carried out. Cells were incubated with 
different S3 concentrations and evaluated by WST-1 cell 
viability assays after 24 h of exposure. The results 
demonstrated that S3 nanoparticles were well-tolerated by 
HeLa cells at concentrations as high as 200 μg·mL-1 (see Figure 
SI-6). Next, the intracellular delivery of the cytotoxic agent 
doxorubicin using S3DOX was studied. Doxorubicin is used in 
cancer therapy in order to kill cancer cells by DNA intercalation 
and oxidative stress. Cell were treated with 50 and 100 μg·mL-1 
S3DOX for 30 min, washed to remove non-internalized 
nanoparticles and further incubated with and without 
acetylthiocholine for 24 h. At lower S3DOX dosage (50 μg·mL-1), 
no reduction in cell viability was observed in the absence of 
acetylthiocoline whereas 20% cell death was induced in the 
presence of the stimulus (see Figure 6). At higher S3DOX dosage 
(100 μg·mL-1), cell viability decreased to around 65% in the 
absence of acetylthiocholine and it was further decreased to a 
remarkable 15% in the presence of acetylthiocholine (see also 
Figure 6). A more efficient elimination of cancer cells was 
achieved when S3DOX and acetylthiocholine were co-
administered. We also checked that acetylthiocholine did not 
have any toxic effect by itself. These results demonstrated that 
cargo release from the Janus nanodevice triggered by 
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acetylthiocholine also works in cells which is a complex high 
competitive medium. 
 
Figure 6. Cell experiments. Top (I): Cell viability assays of HeLa cells treated with 
different concentration of S3DOX (0, 50 and 100 µg·mL-1) in the absence (black 
bars or in the presence (red bars) of acetylthiocholine (40 mM). Three 
independent experiments were done. Data are expressed as mean ± σ. Down (II): 
Controlled release from S3 (100 µg·mL-1) in HeLa cells examined by confocal 
microscopy for (a) control experiment, (b) incubation with S3 and 
acetylthiocholine (40 mM) and (c) incubation with S3. From left to right: cargo 
(safranin O) fluorescence, DNA-marker (Hoechst 3342) fluorescence and 
combined (merge). 
Additionally, we carried out confocal microscopy 
experiments to directly image the payload release from the 
nanodevice in HeLa cells. For this experiments, HeLa cells were 
incubated with S3 (100 µg·mL-1) in the presence or in the 
absence of acetylthiocholine. For visualization, cells were 
stained with DNA-associated dye Hoeschst 3342 and 
intracellular release of S3 was monitored by measuring 
safranin-associated fluorescence. As shown in Figure 6, a 
strong safranin-associated fluorescence was observed upon 
addition of acetylthiocholine due to the enzyme-mediated 
uncapping of the particles. On the other hand, only a slight 
safranin-fluorescence was observed in the absence of 
acetylthiocholine due to a partial rupture of the disulphide 
bond by the reductive environment inside the cells. These 
results were in agreement with WST-1 cell viability assays, thus 
confirming a much more efficient delivery of the cargo into 
cancer cells using the nanodevice in combination with 
acetythiocholine. 
Regarding redox-responsive systems, various examples 
have been designed in the past years with the aim of 
improving the delivery of drugs into cancer cells. In fact, it has 
been shown that the incorporation of redox-sensitive moieties 
in the structure of doxorubicin-loaded biodegradable micelles 
improved tumour growth inhibition in vivo.17 Other authors 
have developed glutathione-sensitive bowl-shaped polymeric 
nanomotors by introducing a disulphide bridge between 
hydrophilic poly(ethylene glycol) and hydrophobic polystyrene 
blocks and showed the intracellular delivery of doxorubicin in 
HeLa cells.18 Also recently, polymeric nanoparticles containing 
disulphide bonds between their network have been developed 
and tested in cells and tumour models.19 Inorganic materials 
containing disulphide bridges in their structure or capped with 
redox-responsive moieties able to realize controlled release of 
drugs have also been reported.20 These recent studies point 
out the current interest in developing redox-sensitive delivery 
systems with optimized design in order to of achieve a better 
efficiency in drug delivery. As we have shown here, the 
incorporation of enzymes in combination with redox-
responsive systems is a suitable strategy to modulate the 
delivery of gated nanodevices. In addition, the presence of 
gold nanoparticles could be of interest for future applications 
in which drug delivery is combined with optical 
hyperthermia.21 
Conclusions 
 In summary, we reported here the design, synthesis and 
characterization of a new enzyme-controlled SS-OEG-gated 
nanodevice based on Janus Au-MS nanoparticles for cargo 
delivery. In particular, the Au-MS nanoparticles were 
functionalized with acetylcholinesterase enzyme on the Au-
face and with disulfide-containging oligo(ethylene-glycol) 
chains on the MS face. Hydrolysis of acetylthiocholine by the 
enzyme resulted in the formation of thiocholine that induced 
cleavage of the disulfide bond in SS-OEG, uncapping of the 
pores and cargo delivery. The nanodevice was opened in the 
presence of acetylthiocholine but not acetylcholine, which 
demonstrates how the assembly of enzymes and molecular 
gates can synergically recognise small differences between 
molecules. Additionally, we found that the kinetics and 
amount of payload delivered can be finely tuned by the 
presence of enzyme inhibitors. Finally, the nanodevice, tested 
in cancer cells, displayed an enhanced cargo delivery (safranin 
O and doxorubicin) upon addition to the culture media of 
acetylthiocholine. Given the number of enzyme-mediated 
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redox processes22 and gated ensembles that can be brought 
together in Janus Au-MS supports, we believe our findings 
could help in the development of new advanced delivery 
systems. 
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